IE
RDHL

Israel Englander’s Redhill Biopharma RDHL Stock Holding History

Israel Englander’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-529
Closed -$74K – 6771
2022
Q4 		$74K Sell
529
-95
-15% -$41.1K ﹤0.01% 5671
2022
Q3 		$314K Buy
624
+251
+67% +$219K ﹤0.01% 5323
2022
Q2 		$324K Buy
+373
New +$512K ﹤0.01% 5301
2022
Q1 		– Sell
-175
Closed -$452K – 7381
2021
Q4 		$452K Buy
+175
New +$700K ﹤0.01% 5141
2019
Q4 		– Sell
-17
Closed -$118K – 4563
2019
Q3 		$118K Sell
17
-49
-74% -$357K ﹤0.01% 3935
2019
Q2 		$427K Sell
66
-33
-33% -$254K ﹤0.01% 3337
2019
Q1 		$819K Sell
99
-203
-67% -$1.61M ﹤0.01% 2983
2018
Q4 		$1.67M Buy
302
+124
+70% +$950K ﹤0.01% 2298
2018
Q3 		$1.57M Buy
178
+152
+585% +$1.24M ﹤0.01% 2607
2018
Q2 		$222K Buy
26
+16
+160% +$102K ﹤0.01% 3527
2018
Q1 		$53K Buy
+10
New +$57.6K ﹤0.01% 3538
2017
Q4 		– Sell
-20
Closed -$212K – 4026
2017
Q3 		$212K Buy
+20
New +$178K ﹤0.01% 3213
2015
Q4 		– Sell
-14
Closed -$178K – 3715
2015
Q3 		$178K Buy
+14
New +$207K ﹤0.01% 3152

Other funds holding RDHL

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Israel Englander's RDHL Position: Q1 2023 in Review

Israel Englander sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 529 shares — an estimated $74K sold.

Israel Englander first reported a position in RDHL in Q3 2015 and held it in 13 quarters. The position peaked at $1.67M in Q4 2018. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Israel Englander reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Israel Englander sold 529 Redhill Biopharma shares in Q1 2023, an estimated $74K.
  • Israel Englander first reported a position in Redhill Biopharma in Q3 2015 and held it in 13 quarters.
  • Israel Englander's Redhill Biopharma position peaked at $1.67M in Q4 2018.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.